1-5 of 5
Authors: Kenichiro Matsuda
Journal Article
PEDT-10 PHASE II TRIAL OF PATHOLOGY-BASED THREE-GROUP TREATMENT STRATIFICATION FOR PATIENTS WITH CNS GERM CELL TUMORS: A LONG-TERM FOLLOW-UP STUDY Open Access
Neuro-Oncology Advances, Volume 4, Issue Supplement_3, December 2022, Page iii11, https://doi.org/10.1093/noajnl/vdac167.038
Published: 03 December 2022
Journal Article
ACT-19 A REPORT OF PHASE I PART OF PHASE I/II STUDY OF MAINTENANCE THERAPY WITH METFORMIN AND TEMOZOLOMIDE FOR GLIOBLASTOMA Open Access
Neuro-Oncology Advances, Volume 4, Issue Supplement_3, December 2022, Page iii9, https://doi.org/10.1093/noajnl/vdac167.032
Published: 03 December 2022
Journal Article
NI-17 Evaluation of preoperative apparent diffusion coefficient (ADC) of peritumoral FLAIR high lesion and histopathological features in patients with glioblastoma Open Access
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii14, https://doi.org/10.1093/noajnl/vdaa143.061
Published: 28 November 2020
Journal Article
ML-09 The REAL-WORLD of Elderly PCNSL Therapy in Tohoku and Niigata Area According to Retrospective Analysis: A Collaborative Investigation of the Tohoku Brain Tumor Study Group Open Access
Neuro-Oncology Advances, Volume 2, Issue Supplement_3, November 2020, Page ii17, https://doi.org/10.1093/noajnl/vdaa143.072
Published: 28 November 2020
Journal Article
NI-14 EVALUATION OF PREOPERATIVE APPARENT DIFFUSION COEFFICIENT (ADC) OF PERITUMORAL LESION FOR PREDICTING SITE PRONE TO RECURRENCE IN PATIENTS WITH GLIOBLASTOMA Open Access
Neuro-Oncology Advances, Volume 1, Issue Supplement_2, December 2019, Page ii28, https://doi.org/10.1093/noajnl/vdz039.126
Published: 16 December 2019
